Drug Type Small molecule drug |
Synonyms |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization CiVi Biopharma, Inc.Startup |
Active Organization CiVi Biopharma, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Scleroderma, Systemic | Phase 3 | US | CiVi Biopharma, Inc.Startup | 13 Mar 2022 |